is tirzepatide a natural peptide first-in-class dual agonist targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management. By acting on multiple metabolic pathways, tirzepatide: Enhances Tirzepatide: 5mg*10 vials - Nexus

We can repeat this medical success story for semaglutide. The researchers warned that cheaper treatments would not address the structural drivers of obesity, including food insecurity, poverty, urbanisation and commercial food environments, and said that coordinated policies and procurement planning would be needed to realise the benefits

But so far, there is no conclusive evidence that semaglutide raises intraocular pressure or leads to glaucoma

Most people lose 56 pounds per month , though results vary

Some of our patients have experienced more substantial weight loss, while others have seen less of a difference